Systematic review / meta-analysis / 2013
Current evidence is insufficient to support green tea for lung cancer prevention or treatment.
A systematic review evaluated 84 publications, including two phase I trials, one surrogate study, and 79 preclinical studies. In smokers, four daily cups of green tea reduced DNA damage, but phase I trials demonstrated no objective tumor responses at maximum tolerated doses. The authors concluded that current evidence cannot support using green tea to prevent or treat lung cancer.
- Study type
- Systematic review
- Who was studied
- Participants in 2 phase I trials, 1 surrogate study, and preclinical models
- What was measured
- Lung cancer prevention, tumor response, and DNA damage
THE PAPER
Green tea and lung cancer: a systematic review.
Fritz H, Seely D, Kennedy DA, Fernandes R, Cooley K, Fergusson D. Integr Cancer Ther, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.